Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
Inflammopharmacology

Open Access 07-11-2024 | Pseudomonas Aeruginosa | Original Article

Unveiling the antimicrobial, antivirulence, and wound-healing accelerating potentials of resveratrol against carbapenem-resistant Pseudomonas aeruginosa (CRPA)-septic wound in a murine model

Authors: Rana Elshimy, Riham A. El-Shiekh, Mona M. Okba, Rehab M. S. Ashour, Marwa A. Ibrahim, Eman I. Hassanen, Hassan Aboul-Ella, Merhan E. Ali

Published in: Inflammopharmacology

Login to get access

Abstract

Pseudomonas aeruginosa is a repertoire of several virulence factors that create a frightening high pathogenicity level as well as high antimicrobial resistance toward commercially used antibiotics. Therefore, finding a new alternative to traditional antimicrobials is a must. Resveratrol is a very famous phytochemical that harbors many beneficial health properties by possessing antibacterial, anti-inflammatory, and antioxidant properties. The current study aimed to explore the antimicrobial efficacy of resveratrol against P. aeruginosa and explore its ability to accelerate wound healing in a murine model. The obtained results revealed the potent antimicrobial, antivirulence, and wound-healing accelerating potentials of resveratrol against carbapenem-resistant P. aeruginosa (CRPA)-septic wounds. It significantly lowered the transcript levels of P. aeruginosa virulent genes toxA, pelA, and lasB. Additionally, resveratrol significantly accelerated skin wound healing by shortening the inflammatory phase and promoting re-vascularization, cell proliferation, re-epithelialization, and collagen deposition. Furthermore, it increased the immunoexpression of αSMA along with a reduction of the mRNA levels of VEGF, IL-1β, and TNF-α genes. Resveratrol has high therapeutic potential for the treatment of P. aeruginosa wound infection and is a prospective and promising candidate for this problem.
Literature
Abdel-Baki PM, El-Sherei MM, Khaleel AE, Abdel-Sattar E, Salem MA, Okba MM (2023) Correlation between secondary metabolites of Iris confusa Sealy and Iris pseudacorus L. and their newly explored antiprotozoal potentials. BMC Complement Med Ther 23(1):465PubMedPubMedCentralCrossRef
Abdel-Sattar E, El-Shiekh RA (2024) Chemical composition and biological activities of genus Ochrosia: a mini review. Phytochem Lett 62:92–111CrossRef
Ali DE, El-Shiekh RA, El Sawy MA, Khalifa AA, Elblehi SS, Elsokkary NH, Ali MA (2024a) In vivo anti-gric ulcer activity of 7-O-methyl aromadendrin and sakuranetin via mitigating inflammatory and oxidative stress trails. J Ethnopharmacol 335:118617PubMedCrossRef
Ali MM, Al-Mokaddem AK, Abdel-Sattar E, El-Shiekh RA, Farag MM, Aljuaydi SH, Shaheed IB (2024b) Enhanced wound healing potential of arabincoside B isolated from Caralluma Arabica in rat model; a possible dressing in veterinary practice. BMC Vet Res 20(1):282PubMedPubMedCentralCrossRef
Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE, Nissen MD, Sloots TP (2009) Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis 63(2):127–131PubMedCrossRef
Bancroft JD, Layton C, Suvarna SK (2013) Bancroft’s theory and practice of histological techniques. Elsevier, Churchill Livingstone
Bilgic T (2021) Comparison of the effect of local and systemic injection of resveratrol on cutaneous wound healing in rats. Int J Low Extrem Wounds 20(1):55–59PubMedCrossRef
Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair and Regeneration 16(1):2–10PubMedCrossRef
Boongapim R, Ponyaim D, Ponyaim D, Phiwthong T, Rattanasuk S (2021) In vitro antibacterial activity of Capparis sepiaria L. against human pathogenic bacteria. Asian J Plant Sci 20(1):102–108CrossRef
Bratu S, Gupta J, Quale J (2006) Expression of the las and rhl quorum-sensing systems in clinical isolates of Pseudomonas aeruginosa does not correlate with efflux pump expression or antimicrobial resistance. J Antimicrob Chemother 58(6):1250–1253PubMedCrossRef
Breidenstein EB, de la Fuente-Núñez C, Hancock RE (2011) Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 19(8):419–426PubMedCrossRef
Cebrián R, Lucas R, Fernández-Cantos MV, Slot K, Peñalver P, Martínez-García M, Párraga-Leo A, de Paz MV, García F, Kuipers OP (2023) Synthesis and antimicrobial activity of aminoalkyl resveratrol derivatives inspired by cationic peptides. J Enzyme Inhib Med Chem 38(1):267–281PubMedPubMedCentralCrossRef
Chadha J, Harjai K, Chhibber S (2022) Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing. Environ Microbiol 24(6):2630–2656PubMedCrossRef
Chen S, Li R, Cheng C, Xu JY, Jin C, Gao F, Wang J, Zhang J, Zhang J, Wang H (2018) Pseudomonas aeruginosa infection alters the macrophage phenotype switching process during wound healing in diabetic mice. Cell Biol Int 42(7):877–889PubMedCrossRef
Christovam AC, Theodoro V, Mendonça FAS, Esquisatto MAM, Dos Santos GMT, do Amaral MEC (2019) Activators of SIRT1 in wound repair: an animal model study. Arch Dermatol Res 311(3):193–201PubMedCrossRef
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2024.
De Oliveira DM, Forde BM, Kidd TJ, Harris PN, Schembri MA, Beatson SA, Paterson DL, Walker MJ (2020) Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33(3):00181–01119CrossRef
Ding Y, Yang P, Li S, Zhang H, Ding X, Tan Q (2022) Resveratrol accelerates wound healing by inducing M2 macrophage polarisation in diabetic mice. Pharm Biol 60(1):2328–2337PubMedPubMedCentralCrossRef
El-Azzouny MM, El-Demerdash AS, Seadawy HG, Abou-Khadra SH (2018) Antimicrobial effect of garlic (Allium sativum) and thyme (Zataria multiflora Boiss) extracts on some food borne pathogens and their effect on virulence gene expression. Cell Mol Biol (Noisy-Le-Grand) 64(10):79–86PubMedCrossRef
El-Shiekh RA, Ali DE, Mandour AA, Meselhy MR (2024a) Essential oils of Plumeria alba L. and Plumeria rubra L. growing in Egypt: GC/MS analysis, molecular dynamics and in-vitro anti-cholinesterase activity. Industrial Crops Prod. 221:119316CrossRef
El-Shiekh RA, Okba MM, Mandour AA, Kutkat O, Elshimy R, Nagaty HA, Ashour RM (2024b) Eucalyptus oils phytochemical composition in correlation with their newly explored anti-SARS-CoV-2 potential: in vitro and in silico approaches. Plant Foods Hum Nutr 79(2):410–416PubMedPubMedCentralCrossRef
El-Shiekh RA, Meselhy MR, Elshimy R, Ibrahim MA, Ali ME, Hassanen EI (2024c) Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice. BMC Complement Med Ther 24(1):224PubMedPubMedCentralCrossRef
Esposito S, Leone S, Noviello S, Fiore M, Ianniello F, Felaco F, Romagnoli F, Sarli E (2008) Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey. Diabet Med 25(8):979–984PubMedCrossRef
Farahpour MR, Pirkhezr E, Ashrafian A, Sonboli A (2020) Accelerated healing by topical administration of Salvia officinalis essential oil on Pseudomonas aeruginosa and Staphylococcus aureus infected wound model. Biomed Pharmacother 128:110120PubMedCrossRef
Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25(4):581–611PubMedCrossRef
Finnan S, Morrissey JP, Ogara F, Boyd EF (2004) Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 42(12):5783–5792PubMedPubMedCentralCrossRef
Galiano RD (2004) Topical VEGF accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164:1935–1947PubMedPubMedCentralCrossRef
Ghadaksaz A, Fooladi AAI, Hosseini HM, Amin M (2015) The prevalence of some Pseudomonas virulence genes related to biofilm formation and alginate production among clinical isolates. J Appl Biomed 13(1):61–68CrossRef
Ghanem DM, Ammar NM, El-Hawary SS, Hamed AR, Hussein RA, El-Desoky AH, Mohamed DA, Mokhtar FA, Okba MM (2024) Effect of Carissa macrocarpa (Eckl.) A. DC. aerial parts on some non-communicable diseases: in vitro study and HPLC-QTOF/MS-MS analysis. Discov Appl Sci. 6(5):1–11CrossRef
Ghotaslou R, Memar MY, Alizadeh N (2018) Classification, microbiology and treatment of diabetic foot infections. J Wound Care 27(7):434–441PubMedCrossRef
Goldufsky J, Wood SJ, Jayaraman V, Majdobeh O, Chen L, Qin S, Zhang C, DiPietro LA, Shafikhani SH (2015) Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing. Wound Repair Reg 23(4):557–564CrossRef
Goll R, Olsen T, Cui G, Florholmen J (2006) Evaluation of absolute quantitation by nonlinear regression in probe-based real-time PCR. BMC Bioinform 7:1–11CrossRef
Grossman MK, Rankin DA, Maloney M, Stanton RA, Gable P, Stevens VA, Ewing T, Saunders K, Kogut S, Nazarian E (2024) Extensively drug-resistant Pseudomonas aeruginosa outbreak associated with artificial tears. Clin Infect Dis 79(1):6–14PubMedCrossRef
Hakansson J, Bjorn C, Lindgren K, Sjostrom E, Sjostrand V, Mahlapuu M (2014) Efficacy of the novel topical antimicrobial agent PXL150 in a mouse model of surgical site infections. Antimicrobal Agents Chemother 58(5):2982–2984CrossRef
Hassan N, Mostafa I, Elhady MA, Ibrahim MA, Amer H (2022) Effects of probiotic feed additives (biosol and Zemos) on growth and related genes in broiler chickens. Ital J Anim Sci 21(1):62–73CrossRef
Hecker A, Schellnegger M, Hofmann E, Luze H, Nischwitz SP, Kamolz LP, Kotzbeck P (2022) The impact of resveratrol on skin wound healing, scarring, and aging. Int Wound J 19(1):9–28PubMedCrossRef
Khalaf AA, Hassanen EI, Zaki AR, Tohamy AF, Ibrahim MA (2019) Histopathological, immunohistochemical, and molecular studies for determination of wound age and vitality in rats. Int Wound J 16(6):1416–1425PubMedPubMedCentralCrossRef
Konyalioglu S, Armagan G, Yalcin A, Atalayin C, Dagci T (2013) Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells. Neural Regen Res 8(6):485PubMedPubMedCentral
Kundin JI (1989) A new way to size up a wound. AJN Am J Nurs 89(2):206–207PubMed
Lakshmanan R, Campbell J, Ukani G, Beringhs AOR, Selvaraju V, Thirunavukkarasu M, Lu X, Palesty JA, Maulik N (2019) Evaluation of dermal tissue regeneration using resveratrol loaded fibrous matrix in a preclinical mouse model of full-thickness ischemic wound. Int J Pharm 558:177–186PubMedCrossRef
Levin-Arama M, Abraham L, Waner T, Harmelin A, Steinberg DM, Lahav T, Harlev M (2016) Subcutaneous compared with intraperitoneal ketamine–xylazine for anesthesia of mice. J Am Assoc Lab Anim Sci 55(6):794–800PubMedPubMedCentral
Liao C, Huang X, Wang Q, Yao D, Lu W (2022) Virulence factors of Pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance. Front Cell Infect Microbiol 12:926758PubMedPubMedCentralCrossRef
Mahdally NH, Salih AE, El-Shiekh RA, Sayed AM, Elhosseiny NM, Kashef MT, Yaseen M, Mackay W, El Halawany AM, Rateb ME (2024) Exploring the antimicrobial activity of Origanum majorana L. against the highly virulent multidrug-resistant Acinetobacter baumannii AB5075: UPLC-HRMS profiling with in vitro and in silico studies. Future J Pharm Sci 10(1):71CrossRef
Mansor MR, Al-Khalidi ZS, Almuhanna EH, Hussein HR, Almulla AF, Alnaji HA (2023) Detection and study nan1 and tox A genes of Pseudomonas aeruginosa in isolates from Otitis media patients considered as virulence factors. Iran J Med Microbiol. 17(1):81–89CrossRef
Matar GM, Ramlawi F, Hijazi N, Khneisser I, Abdelnoor AM (2002) Transcription levels of Pseudomonas aeruginosa exotoxin A gene and severity of symptoms in patients with otitis externa. Curr Microbiol 45:350–354PubMedCrossRef
Mazumdar S, Ghosh AK, Dinda M, Das AK, Das S, Jana K, Karmakar P (2021) Evaluation of wound healing activity of ethanol extract of Annona reticulata L. leaf both in vitro and in diabetic mice model. J Tradit Complement Med 11(1):27–37PubMedCrossRef
Noor S, Zubair M, Ahmad J (2015) Diabetic foot ulcer—a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 9(3):192–199PubMedCrossRef
Omeara S, Nelson E, Golder S, Dalton J, Craig D, Iglesias C, Group, D.S. (2006) Systematic review of methods to diagnose infection in foot ulcers in diabetes. Diabetic Med 23(4):341–347PubMedCrossRef
Pang Z, Raudonis R, Glick BR, Lin T-J, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177–192PubMedCrossRef
Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K (2011) Clinical trials of resveratrol. Ann N Y Acad Sci 1215(1):161–169PubMedCrossRef
Paulo L, Ferreira S, Gallardo E, Queiroz JA, Domingues F (2010) Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. World J Microbiol Biotechnol 26:1533–1538CrossRef
Payne WG, Wright TE, Ko F, Wheeler C, Wang X, Wang MC (2003) Bacterial Degradation of Growth Factors. J Appl Res 3(1).
Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, Fiori B, Caputo S, Tinelli G, Zaccardi F (2019) Diabetic foot infections: a comprehensive overview. Eur Rev Med Pharmacol Sci 23(2 Suppl):26–37PubMed
Prasad ASB, Shruptha P, Prabhu V, Srujan C, Nayak UY, Anuradha CKR, Ramachandra L, Keerthana P, Joshi MB, Murali TS (2020) Pseudomonas aeruginosa virulence proteins pseudolysin and protease IV impede cutaneous wound healing. Lab Invest 100(12):1532–1550PubMedPubMedCentralCrossRef
Ranjbar R, Alam M, Antimicrobial Resistance Collaborators (2022) (2024) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Evid-Based Nurs. 27(1):16CrossRef
Robson MC, Mannari RJ, Smith PD, Payne WG (1999) Maintenance of wound bacterial balance. Am J Surg 178(5):399–402PubMedCrossRef
Ruffin M, Brochiero E (2019) Repair process impairment by Pseudomonas aeruginosa in epithelial tissues: major features and potential therapeutic avenues. Front Cell Infect Microbiol 9:182PubMedPubMedCentralCrossRef
Saeed K, Esposito S, Akram A, Ascione T, Bal AM, Bassetti M, Carnelutti A, Chan M, Davis J, Dryden M (2020) Hot topics in diabetic foot infection. Int J Antimicrob Agents 55(6):105942PubMedCrossRef
Saleh MM, Refa’t AS, Latif HKA, Abbas HA, Askoura M (2019) Zinc oxide nanoparticles inhibits quorum sensing and virulence in Pseudomonas aeruginosa. Afr Health Sci 19(2):2043–2055PubMedPubMedCentralCrossRef
Şener B, Kilic M, Shari FJ, Salahi B, Prakashmishra A, Nigam M, Sharifirad M, Martins N, Fokou P (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6(3):91PubMedPubMedCentralCrossRef
Sharififar F, Moshafi M, Mansouri S, Khodashenas M, Khoshnoodi M (2007) In vitro evaluation of antibacterial and antioxidant activities of the essential oil and methanol extract of endemic Zataria multiflora Boiss. Food Control 18(7):800–805CrossRef
Shevelev AB, La Porta N, Isakova EP, Martens S, Biryukova YK, Belous AS, Sivokhin DA, Trubnikova EV, Zylkova MV, Belyakova AV (2020) In vivo antimicrobial and wound-healing activity of resveratrol, dihydroquercetin, and dihydromyricetin against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Pathogens 9(4):296PubMedPubMedCentralCrossRef
Shim JH, Park J-Y, Lee M-G, Kang HH, Lee TR, Shin DW (2013) Human dermal stem/progenitor cell-derived conditioned medium ameliorates ultraviolet a-induced damage of normal human dermal fibroblasts. PLoS ONE 8(7):e67604PubMedPubMedCentralCrossRef
Simonetti O, Cirioni O, Goteri G, Ghiselli R, Kamysz W, Kamysz E, Silvestri C, Orlando F, Barucca C, Scalise A (2008) Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. Peptides 29(4):520–528PubMedCrossRef
Solanki D, Vinchhi P, Considerations MPD (2023) Design considerations, formulation approaches, and strategic advances of hydrogel dressings for chronic wound management. ACS Omega 8(9):8172–8189PubMedPubMedCentralCrossRef
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318–327PubMedCrossRef
Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomas-Barberan F, Teresa Garcia-Conesa M, Carlos Espin J (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Design 19(34):6064–6093CrossRef
Tyavambiza C, Meyer M, Meyer S (2022) Cellular and molecular events of wound healing and the potential of silver based nanoformulations as wound healing agents. Bioengineering 9(11):712PubMedPubMedCentralCrossRef
Vestergaard M, Ingmer H (2019) Antibacterial and antifungal properties of resveratrol. Int J Antimicrob Agents 53(6):716–723PubMedCrossRef
Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, Pollock D, See I, Soe MM, Walters MS (2020) Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol 41(1):1–18PubMedCrossRef
Wilson JR, Mills JG, Prather ID, Dimitrijevich SD (2005) A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 18(7):373–378PubMedCrossRef
Winstanley C, Kaye SB, Neal TJ, Chilton HJ, Miksch S, Hart CA, Group, M.O. (2005) Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol 54(6):519–526PubMedCrossRef
Yuan JS, Reed A, Chen F, Stewart CN (2006) Statistical analysis of real-time PCR data. BMC Bioinformatics 7:1–12CrossRef
Zhai X-X, Ding J-C, Tang Z-M (2015) Resveratrol inhibits proliferation and induces apoptosis of pathological scar fibroblasts through the mechanism involving TGF-β1/Smads signaling pathway. Cell Biochem Biophys 71:1267–1272PubMedCrossRef
Zhang L-X, Li C-X, Kakar MU, Khan MS, Wu P-F, Amir RM, Dai D-F, Naveed M, Li Q-Y, Saeed M (2021) Resveratrol (RV): a pharmacological review and call for further research. Biomed Pharmacother 143:112164PubMedCrossRef
Zhen X, Lundborg CS, Sun X, Hu X, Dong H (2019) Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control 8:1–23CrossRef
Metadata
Title
Unveiling the antimicrobial, antivirulence, and wound-healing accelerating potentials of resveratrol against carbapenem-resistant Pseudomonas aeruginosa (CRPA)-septic wound in a murine model
Authors
Rana Elshimy
Riham A. El-Shiekh
Mona M. Okba
Rehab M. S. Ashour
Marwa A. Ibrahim
Eman I. Hassanen
Hassan Aboul-Ella
Merhan E. Ali
Publication date
07-11-2024
Publisher
Springer International Publishing
Published in
Inflammopharmacology
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-024-01591-z